Peter K. Watler - Net Worth and Insider Trading

Peter K. Watler Net Worth

The estimated net worth of Peter K. Watler is at least $0 dollars as of 2024-05-05. Peter K. Watler is the Chief Technical Officer of Coherus BioSciences Inc and owns about 0 shares of Coherus BioSciences Inc (CHRS) stock worth over $0. Details can be seen in Peter K. Watler's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Peter K. Watler has not made any transactions after 2016-08-08 and currently still holds the listed stock(s).

Transaction Summary of Peter K. Watler

To

Peter K. Watler Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Peter K. Watler owns 1 companies in total, including Coherus BioSciences Inc (CHRS) .

Click here to see the complete history of Peter K. Watler’s form 4 insider trades.

Insider Ownership Summary of Peter K. Watler

Ticker Comapny Transaction Date Type of Owner
CHRS Coherus BioSciences Inc 2016-08-08 Chief Technical Officer

Peter K. Watler Latest Holdings Summary

Peter K. Watler currently owns a total of 1 stock. Peter K. Watler owns 0 shares of Coherus BioSciences Inc (CHRS) as of August 8, 2016, with a value of $0.

Latest Holdings of Peter K. Watler

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CHRS Coherus BioSciences Inc 2016-08-08 0 2.27 0

Holding Weightings of Peter K. Watler


Peter K. Watler Form 4 Trading Tracker

According to the SEC Form 4 filings, Peter K. Watler has made a total of 0 transactions in Coherus BioSciences Inc (CHRS) over the past 5 years. The most-recent trade in Coherus BioSciences Inc is the sale of 55,621 shares on August 8, 2016, which brought Peter K. Watler around $2 Million.

Insider Trading History of Peter K. Watler

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Peter K. Watler Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Peter K. Watler Ownership Network

Ownership Network List of Peter K. Watler

No Data

Ownership Network Relation of Peter K. Watler


Peter K. Watler Owned Company Details

What does Coherus BioSciences Inc do?

Who are the key executives at Coherus BioSciences Inc?

Peter K. Watler is the Chief Technical Officer of Coherus BioSciences Inc. Other key executives at Coherus BioSciences Inc include director & President and CEO Dennis M Lanfear , Chief Financial Officer Mcdavid Stilwell , and See Remarks Bryan J Mcmichael .

Coherus BioSciences Inc (CHRS) Insider Trades Summary

Over the past 18 months, Peter K. Watler made no insider transaction in Coherus BioSciences Inc (CHRS). Other recent insider transactions involving Coherus BioSciences Inc (CHRS) include a net sale of 223,100 shares made by Dennis M Lanfear ,

In summary, during the past 3 months, insiders sold 0 shares of Coherus BioSciences Inc (CHRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 223,100 shares of Coherus BioSciences Inc (CHRS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 223,100 shares.

Coherus BioSciences Inc (CHRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Coherus BioSciences Inc Insider Transactions

No Available Data

Peter K. Watler Mailing Address

Above is the net worth, insider trading, and ownership report for Peter K. Watler. You might contact Peter K. Watler via mailing address: 235 Berry Street, #609, San Francisco Ca 94158.

Discussions on Peter K. Watler

No discussions yet.